about
Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility.Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registryInfluence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD PatientsBases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel DiseaseEditorial: real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease-results from the ENEIDA registry. Authors' reply
P50
description
researcher (ORCID 0000-0001-7360-7581)
@en
name
Marisa Iborra
@en
type
label
Marisa Iborra
@en
prefLabel
Marisa Iborra
@en
P31
P496
0000-0001-7360-7581